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Highlights 
• The present study examined correlates of stigma in people with epilepsy 
• Thirty-three articles reporting on 25 quantitative studies were identified 
• Stigma was associated with demographic, illness-related, and psychosocial factors 
• Predictors of stigma were highly culturally-specific 




The aim of this review was to identify quantitative correlates, predictors, and outcomes of 
stigma in adults with epilepsy living in Western countries.  
Methods 
To identify relevant literature, four academic databases (PsycINFO, CINAHL, PubMed, and 
Scopus) were systematically searched using key terms related to stigma and epilepsy.   
Results 
Thirty-three research papers reporting findings from 25 quantitative studies of correlates of 
stigma in epilepsy were identified.  The findings suggest that stigma can be predicted by 
demographic, illness-related, and psychosocial factors; although associations were found to 
be highly culturally-specific.  Outcomes of stigma in people with epilepsy were replicated 
more consistently across cultures and its impact was significant.  Detrimental effects included 
both worse physical health, including less effective management of the condition, and 
reduced psychological wellbeing, including difficulties such as depression and anxiety.   
Implications 
Educational initiatives and therapeutic interventions that aim to address stigma in people with 
epilepsy are recommended; however, these need to be culturally-informed to ensure that they 
are valid and effective. 
Keywords: Epilepsy; stigma; neurological conditions; chronic illness; mental health  
1. Introduction 
1. 1 Stigma 
Goffman defined stigma as a phenomenon in which a person is discredited or rejected by 
society because of a particular attribute, in a way that spoils their normal identity [1].  This 
may be due to “external deformations” such as physical disabilities and diseases, “deviations 
in personal traits”, such as being unemployed or addicted to drugs, and “tribal stigmas” based 
on, for example, ethnic group or nationality [1].  Jones et al. [2] developed Goffman’s 
description by defining stigma as a “mark” (attribute) that links a person to undesirable 
characteristics (stereotype).  Crocker, Major, and Steele [3] similarly went on to describe 
stigma as the possession (or believed possession) of an attribute or characteristic that conveys 
a social identity that is devalued in a particular social context.  More recently, Link and 
Phelan summarized that “stigma exists when elements of labelling, stereotyping, separating, 
status loss, and discrimination co-occur in a power situation that allows these processes to 
unfold” [4]. 
1.2 Stigma in epilepsy 
Informed by the work of Goffmann [1], Scambler and Hopkins [5] described how stigma can 
manifest in people with epilepsy (PWE) in their “Hidden Distress Model of Epilepsy”, which 
differentiated between “felt” stigma (e.g., PWE feeling embarrassed or ashamed about the 
condition) and “enacted” stigma [6] (e.g., experiencing discrimination or social exclusion 
from others).  The model highlights the relative importance of felt stigma in comparison to 
enacted stigma, and can be broadly operationalized into three areas: the sense of felt sigma 
that people experience when being confronted by a diagnosis and as a result feeling the need 
to conceal their illness; the impact of this concealment in relation to others being unaware of 
their epilepsy; and the disruption that this felt stigma can cause, which can be even greater 
than when stigma is enacted externally [7].   
1.3 Present context of epilepsy-related stigma 
This review will identify predictors and outcomes associated with stigma for adults in 
Western countries.  Public myths and misconceptions of epilepsy endure [8] often reinforced 
by the use of derogatory language and negative or erroneous media representations [9], and 
PWE continue to face social and legal barriers even in Western countries.  For example, in 
the UK, it was illegal for PWE to marry until as late as 1970 [10].  To protect the rights of 
PWE in England, Scotland, and Wales, epilepsy has been included in the Equality Act [11], 
and in Northern Ireland in the Disability Discrimination Act [12].  However, PWE continue 
to be discriminated against in the UK, for example in regard to employment and driving [13]. 
Thus, although they have diminished over time, stigmatizing negative attitudes towards 
epilepsy, underpinned by misconceptions of the condition and often enacted as 
discrimination, continue to impact on those living with the condition. 
1.4 Justification for a review 
Whilst medical treatments for epilepsy have advanced, stigma around the condition has 
persisted over time [14].  Despite an increased awareness of the causes and effects of 
epilepsy, misconceptions that underpin stigma of the condition have not been eradicated, 
[15].  Previous reviews have described the frequency and nature of stigma towards epilepsy, 
examined misconceptions within the general population, and discussed issues related to 
stigma and quality of life [13,15,16,17,18,19].  The majority of published studies have 
investigated stigma in “Western” or “developed” populations (North America, South 
America, Europe, and Australia).  It is hoped that the findings of this review will help to 
inform the future direction of interventions aimed at reducing the prevalence and impact of 
stigma in PWE in Western countries and encourage further investigation of stigma in other, 
non-Western, populations. 
2. Methods 
2.1 Research aims 
The aim of this review was to identify quantitative correlations, predictors, and outcomes of 
stigma in adults with epilepsy. 
2.2 Inclusion and exclusion criteria  
The following search parameters were chosen to provide a homogenous sample that would 
allow a clear picture to be obtained in relation to the current state of stigma in adults with 
epilepsy in a culturally specific context. 
2.2.1 Inclusion criteria 
• Studies that have quantitatively measured correlates of stigma in adults with epilepsy 
using (a) validated measure(s) of stigma 
• Studies focusing on adult populations (ages ≥ 16 years) 
• Studies published in Western countries (North America, South America, Europe, and 
Australia) 
• Studies published after 2000 
• Studies available in English 
2.2.2 Exclusion criteria 
• Studies using qualitative methods 
• Studies examining misconceptions of epilepsy or perceptions of epilepsy stigma in the 
general population 
• Studies including participants who have had seizures but do not have a diagnosis of 
epilepsy 
2.3 Description of systematic search process 
Following consultation with an academic librarian, four databases were searched: PsycINFO, 
CINAHL, PubMed, and Scopus.  Two key search terms were used: “epilepsy” and “stigma”.  
Use of the truncation symbol in the context of “stigma*”, to include suffixes such as 
“stigmatizing” and “stigmatized”, was discounted as it was felt that this would likely result in 
a more cumbersome search which would not yield additional relevant papers.  Keyword 
searches including the terms “stigma”, “social stigma”, “labelling”, “stereotyped attitudes”, 
“stereotyping”, combined with the term  “epilepsy”, were completed in databases where this 
functionality was available (e.g. Thesaurus in PsychINFO, CINAHL Headings, and Medical 
Subject Headings [MeSH] in PubMed).  This was then combined with a free text search of 
the “abstract” or “title and abstract” fields to identify additional articles missed by index 
searches.  The articles identified across databases were entered into the referencing software, 
Endnote, and duplications were removed.  Articles were then filtered and excluded by title, 
abstract, or full-text according to their relevance to the research question, methodology, date 
and location of publication, and sample population.  Reference lists of included papers were 
also searched for additional relevant articles.  An overview of the search strategy is provided 
in Figure 1. 
[Figure 1 here] 
Once all relevant articles had been identified, the findings were compared and contrasted 
using a narrative synthesis to allow for a meaningful integration and discussion of the 
available evidence.  Due to the heterogeneity of research identified in the review, a meta-
analysis was not undertaken. 
2.4 Appraisal of methodological quality 
To assess the methodological quality of studies included in the review, a quality appraisal 
tool for observational studies adapted from the Agency for Healthcare Research and Quality 
was used [20].  This comprised an eight-point checklist of key methodological considerations 
which researchers should take into account and report in studies of this type, including issues 
relating to sample selection, measures, data handling, and analysis.  Studies were rated on 
each item and assigned an overall score to indicate an appraisal of the methodological 
quality.  To ensure the reliability and validity of appraisal ratings, a sub-sample of six papers 
was chosen at random and peer inter-rated; discrepancies were minor and final ratings were 
agreed by consensus. 
3. Results 
3.1 Synthesis of reviewed studies 
An overview of the studies identified for inclusion in the review is provided in Table 1.  
Correlation coefficients (Pearson’s r) are also presented in Table 1, where available, as a 
measure of effect size [21]. 
[Table 1 here] 
3.2 Study characteristics 
Following the search procedure described above, 33 research papers were identified, 
reporting findings from 25 quantitative studies, with 16,942 adults with epilepsy.  An 
additional 238 adults without a diagnosis of epilepsy were recruited as controls.  Participant 
ages ranged from 16-98 years.  Research was identified from countries in North and South 
America, Europe, and Australia.  There were 12 papers from the US, five from Bulgaria, four 
from Turkey, three from the UK, three from countries across Europe, two from Australia, one 
from the Netherlands, one from Croatia, one from Mexico, and one from Canada.  Of the 
studies identified, 30 were cross-sectional in design and three incorporated longitudinal 
methods.  Two studies compared findings to controls without epilepsy.  Eight papers used 
only correlational analyses and 25 included regression analyses. 
3.3 Measures 
The papers identified in the review used 10 different standardized measures of stigma.  
Fifteen papers used the “Jacoby 3-Item Measure of Stigma” [22], which was the most widely 
used measure in the review.  Twelve papers used the “Modified Parent Stigma Scale”, also 
referred to as the “Epilepsy Stigma Scale (ESS)” [23].  Of the remaining studies, individual 
papers used the “Felt Stigma Scale” [24], the “Perception of Stigma of Epilepsy Scale (PSE)” 
[25], the “Revised Stigma Scale” [26], the “Stigma Scale” [27], the “Stigma Scale for People 
with Intellectual Impairment” [28], and stigma items derived from the “Child Asthma Scale” 
[29].  
3.4 Scope of the research 
The identified studies examined correlations, predictors, and outcomes of stigma in adults 
with epilepsy.  Statistical data regarding epilepsy epidemiology or stigma prevalence was not 
addressed in this review.  Whilst the majority of research was cross-sectional in design, and 
therefore directionality of effect or causation could not be determined, researchers typically 
framed their findings in relation to what they viewed as predictors or outcomes of stigma 
within the target population. 
3.5 Summary of quality appraisal 
Overall, the methodological quality of studies in the review was satisfactory, with a mean 
score of 5.5 out of 8, although this ranged from 2.5 to 7 indicating variability of quality 
across studies (see Table 1).  Most studies provided clear descriptions of participant samples, 
including details of inclusion/exclusion criteria and how participants were recruited.  Details 
of statistical analyses were generally provided and appropriate for the type of study.  
Consideration of confounding data was also widely taken into account, with the majority of 
studies using regression analyses to adjust for demographic or clinical factors likely to be 
correlated with outcomes.  However, power calculations as a means of determining and 
justifying sample size were reported in only two studies.  Validity of standardized measures 
was frequently referred to in relation to findings of previous studies; however reliability 
coefficients (e.g. Cronbach’s alpha) were rarely given, therefore validity and reliability could 
not be fully assumed [30].  Details of missing data were also rarely reported; again this limits 
confidence that data was obtained and presented in a way which minimizes bias.   
3.6 Summary of main findings  
3.6.1 Demographic, illness, and psychosocial correlates and predictors of stigma 
Twenty studies examined correlations or predictors of stigma in PWE.  Findings could be 
broadly categorized according to demographic, illness-related, and psychosocial variables 
found to be correlated with, or (for regressions) to predict, stigma. 
3.6.1.1 Demographic variables 
 3.6.1.1.1 Socioeconomic factors 
Several socioeconomic factors were identified as important.  Yeni, Tulek, and Bebek 
identified a negative correlation between income and stigma [31].  Higher income was also 
found to predict lower stigma when other variables had been taken into account [32,33].  In a 
further regression study, Smith et al. found that people who were disabled or unemployed 
with greater seizure worry were more likely to report higher levels of stigma when adjusting 
for other variables (e.g. self-efficacy, social support, and race) [34].  Yeni, Tulek, and Bebek 
also identified a negative correlation between education and stigma [31].  In correlational 
studies comparing patients from clinics in “low and high sociodemographic communities”, 
participants from low socioeconomic status backgrounds were found to report higher felt 
stigma [35,36]; although when psychosocial variables including quality of life (QOL), 
depressive symptoms, and social support were entered into a regression model, these 
differences were found not to be significant [36].  These findings indicate that socioeconomic 
status may not in itself significantly affect stigma but that other related psychosocial variables 
may be of greater importance. 
3.6.1.1.2 Cultural factors 
The impact of cultural factors was also identified.  In a large-scale continental study 
examining the relationship between stigma and health system performance across 10 
European countries, including a sample of over 5,000 PWE, Baker et al. found country of 
origin to significantly contribute to variance in reported levels of stigma in regression 
analyses [37].  For example, Spanish participants reported significantly lower levels of stigma 
than participants in France.  The authors suggested that cultural differences may be due to a 
range of factors, including sociocultural bias against epilepsy, cultural norms, the structure of 
the health system, and the existence of high profile public figures with the condition who may 
act as role models, although they suggested that more research is needed.  Brigo et al., 
reporting on the same data, identified a trend towards negative correlation between stigma 
and overall health system performance and health expenditure per capita; however, this 
association was non-significant [38]. 
3.6.1.1.3 Personal factors 
Personal factors were also identified as potentially contributing to variance in stigma.  When 
taking into account other clinical and demographic variables using regression analyses, Baker 
et al. identified that being married significantly predicted lower levels of stigma, alongside 
six other important illness-related and psychosocial variables [37].  Bautista, Shapovalov, and 
Shoraka replicated this finding [32].  Younger age was also found to be correlated with 
higher stigma in some studies [32,39,40]; this was found to independently predict lower 
levels of reported stigma when other variables had been taken into account in regression 
analyses [26].  In contrast, however, several other studies using regression analyses did not 
find age to significantly predict stigma [31,33,36,41,42].  Gender was also found to be 
uncorrelated with stigma [33,36,41,43].  It has been suggested that a lack of relationship 
between gender and stigma may be due in part to overarching negative social attitudes, which 
can cause other factors to “recede into the background” [43]. 
3.6.1.2 Illness-related variables 
3.6.1.2.1 Seizure type and severity 
Ni Eidhin and McLeavey found seizure type and severity to correlate significantly with 
stigma [44], although significant flaws were identified in their methodology.  Baker also 
found seizure type (generalised seizures) to contribute to variance in stigma outcomes in 
regression analyses [45]; however, he stressed that the relevant contributions of these 
findings depended on the country of origin of those surveyed, highlighting the importance of 
cultural differences in determining the impact of illness-related variables on stigma.  In 
contrast, in regression analyses Baker et al. found epilepsy-related injuries to significantly 
contribute to scores of stigma but not seizure type [37].  Viteva found no correlation between 
stigma and seizure severity [43]. 
3.6.1.2.2 Seizure frequency 
Dilorio et al. found the number of seizures experienced during the past year to significantly 
predict stigma in regression analyses [33], and this was replicated in Croatian and UK studies 
using regression models which found number of seizures to date to significantly predict 
stigma [26,39].  Yeni et al. also identified positive correlations between seizure frequency 
and stigma [46].  Furthermore, Baker’s large-scale study in European countries found greater 
seizure frequency to be the most consistent cross-cultural predictor of higher levels of 
reported stigma in regression analyses [45].  However, these findings were partially in 
contrast to those of a large-scale study by Baker et al., which found that whilst seizure 
frequency significantly correlated with measures of stigma, this variable did not predict 
significant variance in stigma when entered into a regression model alongside other variables 
including age at onset, marital status, worry about epilepsy, injury, feelings about life, general 
health, and duration of epilepsy [37].  Aydemir, Kaya, Yıldız, Öztura, and Baklan also found 
that number of seizures did not significantly predict stigma in regression analyses [41], and 
Viteva found no correlation at all between stigma and seizure frequency [43]. 
3.6.1.2.3 Epilepsy onset 
The age of epilepsy onset (i.e. longer duration of epilepsy) was found to significantly 
correlate with stigma [46] and to contribute to higher scores of stigma in several regression 
studies [33,37,45].  However, cultural variations were again identified [37].  In another 
regression study, Smith et al. found that those with later seizure onset were more likely to 
report lower levels of stigma but only when they were experiencing a higher quality of care 
[34].  In contrast, Aydemir, Kaya, Yıldız, Öztura, and Baklan did not find duration of 
epilepsy to significantly predict stigma in regression analyses [41]. 
3.6.1.2.4 Epilepsy treatment 
Aydemir, Kaya, Yıldız, Öztura, and Baklan found that taking a greater number of epilepsy 
medications was correlated with increased stigma [41].  Yeni et al. also identified positive 
associations between the use of epilepsy medication and stigma [46].  However, in contrast, 
Viteva found no correlation between stigma and prescribed treatment [43].  Observed 
associations may be due in part to iatrogenic effects of treatments.  When taking into account 
other illness-related variables in regression analyses, adverse events and side effects relating 
to the use of anti-epileptic drugs were found to significantly predict stigma [26,47].  
Aydemir, Özkara, Canbeyli, and Tekcan also examined the effects of epilepsy surgery by 
comparing participants who had already received surgery to those who were awaiting surgery 
using t-tests [48].  The authors found no significant differences in the pre- and post-surgery 
groups, which they argued might have been due to the long-term effect of being labelled as 
“epileptic”, even if epilepsy has gone into remission.  It is also possible that for some people 
stigma related to refractory epilepsy (e.g. seizures) was replaced by stigma related to surgery 
(e.g. visible scarring), although this was not included in analyses. 
3.6.1.3 Psychosocial variables 
3.6.1.3.1 Psychological factors 
Psychological and emotional factors which were found to predict higher levels of reported 
stigma in regression analyses included feelings about life and perceived impact of epilepsy 
[37], lower self-efficacy [33,34], lower patient satisfaction [33], feeling more socially 
restricted, and poor overall global QOL [26].  Social anxiety was also found to predict stigma 
in regression analyses, over and above depression and other types of anxiety [42].  Cognitive 
factors which were found to predict stigma variance in regression models included concerns 
related to social life and future occupation [41], negative outcome expectancies for seizures 
[33], and perception of the role of genetics in determining the condition [49].  Although 
previous research describes important differences between felt and enacted stigma [7], 
authors of the studies identified did not typically differentiate between the two; although in 
one study enacted stigma was found to predict felt stigma, with those experiencing 
discrimination, insults, threats or attacks reporting higher levels of the felt stigma [40].  
Behavioral factors were also found to be important.  After controlling for demographic and 
clinical variables including age, gender, duration of epilepsy, number of seizures, and number 
of medications using regression analyses, Aydemir, Kaya, Yıldız, Öztura, and Baklan found 
concealment of epilepsy to significantly predict felt stigma [41].  Similarly, the use of 
behavioral disengagement, a coping strategy whereby a person intentionally decreases the 
amount of effort needed to deal with a stressful situation, was also found in regression 
analyses to be independently associated with higher reported stigma [32]. 
3.6.1.3.2 Relational factors 
Social support was found to be important.  In a correlational study, participants with greater 
social support reported significantly lower stigma [31].  Furthermore, social support was 
found to significantly predict lower stigma even when other sociodemographic variables had 
been taken into account in regression analyses [36].  To ascertain whether participants’ social 
cognitive skills and their ability to understand the thoughts, intentions, beliefs, and emotions 
of others contributed to feelings of stigma, Noble, Robinson, and Marson compared “theory 
of mind” and stigma measures using regression analyses [50]; these were found to share little 
variance, regardless of participant seizure status, indicating that the model has little utility in 
understanding epilepsy stigma. 
3.6.1.3.3 Knowledge and access to information 
Access to understandable information was also found to be important.  Correlational studies 
identified negative associations between knowledge and attitudes towards epilepsy (increased 
knowledge and more positive attitudes) and stigma [31,46].  After taking into account 
demographic and clinical variables using regression analyses, Baker also found knowledge of 
epilepsy to negatively predict stigma [45].  Similarly, difficulties in understanding written 
information, which may limit access to epilepsy knowledge, were found to predict higher 
levels of stigma in regression analyses [32]. 
3.6.2 Stigma as a predictor and correlate of wellbeing 
Seventeen studies examined correlations between stigma and condition management, 
physical health, or psychological wellbeing, with 11 studies then going on to use more 
complex models (e.g.. regression or mediation) where stigma was a predictor of physical and 
psychological wellbeing. 
3.6.2.1 Physical wellbeing and condition management 
Chesaniuk, Choi, Wicks, and Stadler found that higher perceived stigma was correlated with 
lower medication adherence; mediation analyses revealed this association to be explained 
largely by information, motivation, and behavioral skills [51].  Similarly, using path analysis, 
Dilorio, Shafer, Letz, Henry, and Schomer found stigma to be indirectly related to medication 
self-management through its association with self-efficacy [52].  The association between 
stigma and lower self-efficacy was supported by a correlational study by Yeni et al., who 
found participants reporting higher levels of stigma to be more likely to hide their condition 
from others and more likely to seek help from non-medical sources such as “mystics” [31].  
In a regression study, Dilorio, Shafer, Letz, Henry, and Schomer found stigma to predict 
seizure severity [53], which they argued may be related to poor self-management or help-
seeking behaviors; although it is possible that people who experience more seizures may be 
more likely to experience greater discrimination.  Stigma was also found to be negatively 
correlated with social support [54] and epilepsy outcomes, including being identified as a 
significant predictor of “concerns about the social impact of epilepsy” alongside seizure 
severity in regression analyses [27].  These findings may help to explain those identifying 
positive correlations between seizure severity and social support and stigma discussed above 
[34,44], and brings into question the causal direction of these relationships.  In contrast to 
other studies, Elliott, Jacobson, and Seals did not find stigma to predict self-efficacy or 
epilepsy self-management in regression analyses [55].  The authors of this study identified 
age and ethnicity as the only predictors of these variables, highlighting the potential 
importance of demographic and cultural factors in determining health outcomes alongside 
stigma.  
3.6.2.2 Psychological wellbeing and QOL 
There was also evidence that stigma can affect psychological wellbeing and QOL.  In several 
studies, stigma was positively correlated with depression and anxiety [31,35,36,43,52,53,54].  
These findings were supported by a longitudinal study completed by Reisinger and Dilorio, in 
which stigma was found to be the third most important predictor of depression following 
employment status and social support, after controlling for demographic and seizure-related 
variables using regression analyses [56].  Similarly, in another regression study, stigma was 
found to predict depression and anxiety when gender, age, and epilepsy-related variables had 
been controlled for [57].  Viteva also found that stigma correlated with affective and 
obsessive compulsive disorders (defined by the authors as “mental status impairment”) [43].   
In addition to depression and anxiety, Viteva found stigma to negatively correlate with QOL 
[27]. Regression studies also found stigma to predict poor health-related quality of life 
(HRQOL), reduced psychosocial function, and lower “emotional wellbeing” when other 
variables had been accounted for [58,59].  Similarly, in regression analyses Suurmeijer, 
Reuvekamp, and Aldenkamp found perception of stigma to be the fourth strongest predictor 
of low QOL after psychological distress, loneliness, and adjustment and coping; this 
association was significant regardless of participants’ physical status [60].  Eidhin and 
McLeavey also found stigma to be significantly correlated with lower perceived acceptance 
of the condition, with participants with higher stigma feeling less cared for and less valued by 
others [44]. 
4. Discussion 
4.1 Key findings 
The findings of the review suggest that stigma is a complicated construct to understand in the 
context of PWE and is associated with a range of important factors.  A number of 
demographic variables were found to be associated with stigma, although these findings were 
not replicated across all studies.  Being married, higher income, and higher age were found to 
be associated with lower levels of stigma.  Being in a stable relationship may help to protect 
or mitigate against social rejection and the identification of an individual as “discredited” or 
having a “spoiled identity” [1], through the social support offered by partners/spouses [61].  
In general, those with access to greater financial resources and social support may be better 
able to cope with adversity [62,63].  Financial resources may be particularly relevant to PWE 
if it helps them to overcome limitations, for example paying for taxis may help to mitigate 
against the impact of being unable to drive and lead to feeling more included.  Older age has 
also been associated with increased resilience, which may be due to the development of 
coping skills and emotional regulation abilities [64]; this may again help to protect against the 
negative impact of externally-enacted stigma associated with the condition. 
The review also highlighted differences in relation to illness-related variables.  Findings 
associated with seizure type and severity were mixed.  Some studies found these factors to be 
associated with increased stigma whilst elsewhere the finding was not replicated.  Regression 
analyses revealed that other illness-related variables such as age of epilepsy onset (lower age 
associated with higher stigma), number of seizures to date (greater number associated with 
higher stigma), and injuries associated with epilepsy, may be more important.  Seizure 
frequency, whilst found to be associated with stigma, may also be less important in predicting 
stigma than the duration and impact of the condition, perhaps due to repeated exposure to 
negative health-related events, including experiences of discrimination by others.  The 
cumulative number of seizures experienced may also increase the number of negative 
reactions from others (enacted stigma) and an increased perception of self as “externally 
deformed” (felt stigma), [1,6].  This longer-term exposure to seizures and negative reactions 
from others may also lead to an over-identification with the condition, exacerbated by 
negative language or labelling. 
The findings of the review also suggested that the impact of illness-related variables on 
stigma can vary by country of origin, and therefore appeared to be, to a significant degree, 
culturally-specific.  Stigma in epilepsy is highly culturally-dependent [37] and this has been 
highlighted in previous research; for example, a recent cross-continental comparative study of 
PWE found Swedish participants to report significantly lower levels of stigma than PWE in 
Iran; the researchers argued that this was likely due to differences in medical treatment and 
educational exposure [65].  These cultural differences informed the rationale to focus the 
review on countries of Western origin, however there was still considerable heterogeneity 
identified across studies of different geographical origin.   
One possible explanation relates to the impact of overall health system performance and 
health expenditure; the hypothesis being that higher expenditure will result in lower stigma as 
a result of greater understanding of the condition and better support systems.  However, Brigo 
et al. found that, whilst there was a trend towards negative associations between expenditure 
and stigma, findings related to these variables were non-significant [38].  This suggests that 
general investments in public health systems do not necessarily lead to improvements in 
stigma-related epilepsy.  To achieve this, the authors argue, funds need to be directed 
specifically towards epilepsy awareness and stigma-reduction programs.  Whilst public myths 
and misconceptions remain even in countries of higher socioeconomic status where 
educational campaigns have been launched [8,66], the negative impact of stigma on social 
identity in PWE can be greater in resource-poor countries [67].  Concealment of the condition 
in these countries is also likely to be higher [68], and issues of language and legality may 
increase the risks of stigma further [69].  It is therefore important that stigma reduction efforts 
are viewed as important and are culturally-informed [70]. 
Further variance in stigma can be explained by psychosocial factors.  Knowledge of epilepsy, 
and the ability to access this, was universally found to be associated with lower stigma.  
Knowledge of epilepsy is also an important factor in optimizing control of seizures [71]; this 
may impact further on stigma and help to explain some of the geographical differences in 
stigma identified in different countries.  Unsurprisingly, therefore, feelings of control and 
mastery over the condition were found to be negatively associated with perceptions of stigma.  
Where PWE reported lower feelings of self-efficacy or a deterministic view of the condition, 
or where they identified concerns about their ability to effectively manage their illness, to 
access support, or to cope in the future, stigma was higher.  Such beliefs may also lead to 
maladaptive and avoidant coping strategies, such as concealment of the condition or 
behavioral disengagement with its management, which were found to increase stigma 
[32,41].  This could furthermore serve to reinforce a lack of social support, condition 
management, and perceived ability to cope, completing a vicious cycle that provides a fertile 
ground for perceived stigma in PWE.  In this case, stigma may be seen as self-perpetuating, 
and again fits in with Scambler’s “Hidden Distress Model of Epilepsy”, in which a person 
feels stigmatized, conceals their condition from others, and feels increasingly distressed [6].  
Therefore, in addition to wider societal educational campaigns, therapeutic interventions at an 
individual level are also likely to be important. 
The findings associated with outcomes of stigma were more straightforward and perhaps less 
surprising.  Higher levels of stigma were associated with a reduced sense of self-efficacy, 
lower motivation, and compromised condition management, characterized by lower 
medication adherence and poor epilepsy outcomes, including increased seizure severity.  As 
previously identified, however, it was not possible to determine causal directions and it is 
likely that these relationships are strengthened in both directions.  Stigma was found 
universally to predict depression and anxiety, even when other variables had been taken into 
account, as well as being associated with lower “emotional wellbeing, lower perceived 
acceptance, and a greater incidence of obsessive compulsive disorders and low QOL.   
4.2 Implications and recommendations 
The findings of the review suggest that, in addition to demographic and illness-related 
variables, psychosocial factors are likely to be particularly important in determining stigma.  
These are likely underpinned by knowledge about the condition, social support, and a 
perception that the care system, and in turn society, takes an understanding view of epilepsy 
and its management. Public campaigns to address educational deficits have been advocated 
[72,73].  In the UK, this has been reflected by clinical guidelines that explicitly outline the 
responsibility of healthcare professionals to educate others about epilepsy as a means of 
reducing stigma [74], and awareness campaigns launched by charities [75,76].  Where such 
campaigns have been introduced, there has been some evidence of effectiveness [77].  
However, there is contradictory evidence that attitudes over the last 10 years may actually 
have worsened [78], perhaps due in part to online social networking platforms where 
derogatory communications about epilepsy and seizures are common, and in part to a 
negative economy and changes in the global political landscape, where people may have 
become less tolerant of diversity and immigration, fueling negative attitudes towards the 
condition [79].   
Societal values which can lead people to feel stigmatized and to conceal health conditions 
such as epilepsy can also extend to the law [80], therefore further research is needed to ensure 
that legal structures serve to protect PWE.  PWE who feel stigmatized by others are more 
likely to feel depressed and anxious [e.g. 56]; they may also feel less accepted and valued by 
others [44].  Everyone in society, including politicians, teachers, healthcare professionals, 
employers, community leaders, voluntary organizations, PWE and their friends and families 
should therefore help to give PWE a voice, and to promote the view that epilepsy is a 
manageable, socially acceptable, condition.  There is some evidence that psychological 
approaches such as acceptance and commitment therapy (ACT [81]) and compassion focused 
therapy (CFT; [82]) can help to increase psychological flexibility and reduce internalized 
health-related stigma [83].  Narrative therapy may also be beneficial in shedding light on 
alternative perspectives and helping PWE to develop new narratives about themselves [84].  
Hence psychologists working in health settings arguably have a key role to play in tackling 
stigma at a wider societal level as part of their widening influence in public health initiatives 
[85]. 
4.3 Limitations and recommendations for further research  
One of the most significant limitations of this review was that it relied heavily on cross-
sectional surveys gathering data via self-report measures, thus it was not possible to 
determine causation [86] and relationships in this context may therefore be bidirectional with 
one factor reinforcing another. Cross-sectional designs have also been criticized for assuming 
that variables remain stable over time and for therefore failing to address chronological 
variability, leading to biased estimates and incorrect inferences [87].  Further research should 
aim to incorporate longitudinal methods to help determine causation and chronological 
variation.  Another limitation is that findings derived from self-report measures are open to 
bias [88] and sensitive to culture [89], therefore the use of such measures in different 
countries requires careful consideration.  
A large number of studies used a three-item measure of stigma originally used in a study of 
stroke patients [90], adapted for use in PWE by Jacoby [22].  Although this measure has been 
validated for use in this population [22,91], the measure is basic and may not detect subtle but 
important nuances such those associated with “felt” versus “enacted” stigma.  This may be a 
significant omission as, for example, subtle differences in others’ language may be perceived 
as stigmatizing by a person with epilepsy even where this is not intentionally or objectively 
enacted [92].  Further research should aim to use more detailed measurement tools and 
consider this distinction, particularly as  enacted stigma may point towards a need to direct 
change at public health level, whereas felt stigma may require support and interventions at an 
individual level. 
A final limitation related to differentiating Western versus non-Western populations.  Whilst 
the decision was pragmatic and informed by an aim to address a defined research question, it 
is important to acknowledge that the “othering" - and potential stigmatizing - of different 
social, cultural, and geographic groups may be perceived as in direct contrast to the spirit of 
this review.  This is an entirely unintended consequence of the limited scope of the work, 
which reviews of other populations could address. The study of stigma in populations 
globally should be encouraged. 
4.4 Conclusions 
The findings of this review suggest that stigma in PWE may be predicted by demographic, 
illness-related, and psychosocial factors, with the latter explaining a large degree of variance.  
However, findings varied significantly by country of origin.  This suggests that stigma is, to a 
significant degree, culturally determined and thus may present challenges to campaigners and 
legislators attempting to reduce stigma and its impact internationally.  What appears to be 
important, however, is fostering education and understanding of the condition, both in PWE 
and in the general population.  The outcomes of stigma appear significant and more 
universal; its impact relates to both physical health, including management of the condition, 
and psychological wellbeing, including difficulties such as depression and anxiety.  It is 
therefore important that healthcare providers, legislators, policy-makers, and citizens take 
steps to try and address stigma to help improve outcomes for this often marginalized 
population. 
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 Table 1. Characteristics of the studies included in the review 
 










n = 20 patients 
awaiting epilepsy 
surgery and n = 21 
who had already 
undergone surgery 
in Turkey (N = 41; 
mean age = 25.9 
years) 
Jacoby 3-item measure of 
stigma, the Perceived Impact 
of Epilepsy Scale, the Medical 
Outcomes Study Short Form-
36 (SF-36), Beck Depression 
Inventory (BDI), State–Trait 
Anxiety Inventory (STAI) 
T-test; Mann-
Whitney U 
Not reported No significant difference was 
found relative to stigma levels 
between pre- and post-SAH 
groups (p=.82). A high level of 
stigma was observed in only 6 
(14.7%) of the patients, suggesting 
that stigmatization may be low 
among Turkish patients. 
4.5 
Aydemir, Kaya, 






N = 200 adults with 
epilepsy in Turkey 
(age = 18-68 years, 
mean age = 31.68 
years) 
The Felt Stigma Scale, the 
Concealment of Epilepsy 
Scale, the Epilepsy Concern 






Stigma and overprotection 
(r=.34). 
Stigma and concealment 
(r=.64). 
Stigma and future 
occupation concerns 
(r=.62). 





Stigma and number of 
medications (r=.21). 
Concealment of epilepsy (β = .43, 
p < .001), concerns related to 
social life (β = .27, p < .001), and 
concerns related to future 
occupation (β = .26, p < .001) 
were found as the predictors of felt 
stigma after controlling for 
demographics (age and gender), 
and clinical variables 
(duration of epilepsy, number of 
seizures, and number of 
medications). 
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N = 5211 adult 
epilepsy patients 
living in 15 
European countries 
(69% from France, 
UK, Germany, and  
the Netherlands) 
(age = 16+ years, 
mean age = 35 
years) 
Jacoby 3-item measure of 
stigma, Perceived Impact of 
Epilepsy Scale, Extent of 
Worry over Epilepsy, the 
Medical Outcomes Study Short 
Form 36 (SF-36), Terrible-





Not reported Impact of epilepsy (β = .43, 
p < .0001), age of onset (β = .09, 
p < .0001), country of origin, 
feelings about life (β = .05, 
p < .001), and injuries associated 
with epilepsy (β = .05, p < .01) 
were significant contributors to 
stigma. Whereas seizure type and 
frequency were significantly 
correlated with scores on the 
stigma scale, results of the 
multiple regression showed that 
neither seizure frequency nor 
seizure type accounted for a 
significant amount of the variance 




Nardone, and Otte 
(2015) 
 
*Used the same 





N = 5211 adult 
epilepsy patients 
from 10 European 
countries including 
France, UK, 
Germany, and the 
Netherlands (age = 
16-98 years, mean 
age = 37 years) 
Percentages of people with 
epilepsy with epilepsy-related 
stigma obtained from Baker et 
al.’s (2000) study (which used 
the Jacoby 3-item measure of 
stigma), data on overall health 
system performance in 1997, 
data on health expenditure per 




Stigma percentage and 
health system performance 
(r=-.16). 
Stigma and health 
expenditure per capita (r=-
.24). 
Stigma and quality of life 
(r=-.33). 
Authors found a non-significant 
trend towards negative correlation 
between the epilepsy-related 
stigma percentage and the overall 
health system performance (r=-
0.16; p=0.57), the health 
expenditure per capita in 
international dollars (r=-0.24; 
p=0.4), and the Economist 
Intelligence Unit's quality-of-life 
index (r=-0.33; p=0.91). 
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N = 6156 adult 
epilepsy patients 
from 10 European 
countries including 
France, UK, 
Germany, and the 
Netherlands (age = 
16-98 years, mean 
age = 37 years) 
Jacoby 3-item measure of 
stigma, the Epilepsy 
Knowledge Questionnaire, the 
Impact of Epilepsy 
Questionnaire, and the 






Not reported After taking into account 
demographic and clinical 
variables, a number of factors 
were predictive of stigma, 
including seizure frequency, 
knowledge of epilepsy, duration of 
epilepsy, and seizure type. The 
relative contributions of these 
factors varied depending on the 









N = 182 adults with 
epilepsy at epilepsy 
centers in the US 
(mean age = 43 
years) 
The Epilepsy Stigma Scale 
(ESS), the Quality of Life in 
Epilepsy-10 (QOLIE-10), the 
Beliefs about Medicine 
Questionnaire (BMQ), the 
Short Test of Functional Health 
Literacy in Adults 







Stigma and age (r=−.164). 
Stigma and QOL (r=.36). 
Stigma and use of denial 
(r=.15). 
Stigma and behavioural 
disengagement (r=.33). 
Stigma and venting (r=.2). 
Using multiple linear regression, 
marital status (being single) (β = -
4.027, p=.01), being poorer, 
indicated by higher QOLIE-10 
scores (β = .45, p< .01), 
difficulties understanding written 
information (β =-2.19, p=.03), and 
the use of behavioral 
disengagement (β =2, p=.01) were 
independently associated with 
poorer scores on the Epilepsy 
Stigma Scale. 
6 











n = 167 patients 
from a “high 
socioconmic status” 
epilepsy clinic and n 
= 71 from a “low 
socioeconomic 
status” clinic in the 
US (N = 238 ; age = 
18+ years, mean age 
= 40.9 years) 
Modified Parent Stigma Scale, 
Epilepsy Self-Management 
Scale, Epilepsy Knowledge 
Scale, Epilepsy Self-Efficacy 
Scale, Treatment Outcome 
scale, Shared control portion of 
the Multidimensional Desire 
for Control Scale, Personal 
Resource Questionnaire 85, 
Part 2 (PRQ85-2), Center for 
Epidemiologic Studies 











Stigma, along with self-efficacy, 
depression, social support, desire 
for control, and outcome 
expectations, was higher for those 
of high socio-economic status 






*Used the same 
sample as Begley 




n = 167 patients 
from a “high 
socioconmic status” 
epilepsy clinic and n 
= 71 from a “low 
socioeconomic 
status” clinic in the 
US (N = 238 ; age = 
18+ years, mean age 
=  40.9 years) 
Modified Parent Stigma Scale, 
Epilepsy Self-Management 
Scale, Epilepsy Knowledge 
Scale, Epilepsy Self-Efficacy 
Scale, Treatment Outcome 
scale, Shared control portion of 
the Multidimensional Desire 
for Control Scale, Personal 
Resource Questionnaire 85, 
Part 2 (PRQ85-2), Center for 
Epidemiologic Studies 








Stigma and QOL (r=.41) 
Stigma and social support 
(r=− .39). 
Stigma and self-efficacy 
(r=−.21). 
Reported levels of stigma were 
higher in low SES than in high 
SES (p<0.0001), and all 
psychosocial variables were 
associated with stigma, including 
depression severity (p<0.0001), 
knowledge of epilepsy (p=0.006), 
quality of life (p<0.0001), social 
support (p<0.0001), and self-
efficacy (p=0.0009). Stigma was 
statistically significantly 
associated with quality of life in 
the low SES group and with 
depression severity and social 
support in the high SES group. 
5 












N = 298 epilepsy 
outpatients in 
Croatia (age = 17-82 
years, mean age = 
45 years) 
Revised version of the Jacoby 
3-item measure of stigma, 






Not reported Feelings of stigma were 
significantly associated with age, 
younger age of epilepsy onset, 
more than 50 seizures to date, 
generalized tonic-clonic seizures, 
and a shorter seizure-free period. 
Multiple stepwise regression 
showed number of seizures to date 
as a significant variable (B=0.246). 
7 
Chesaniuk, Choi, 





N = 140 PWE in the 
US (age= 20-65 
years,  mean age = 
38.51 years) 
The Epilepsy Stigma Scale, 
Knobel Brief Adherence 
Questionnaire, adapted scale of 
adherence information, 






Stigma and medication 
adherence (r=−.18). 
Stigma and levels of 
information (r=−.28). 
Stigma and motivation 
(r=−.55). 
Stigma and behavioral 
skills (r=−.41).  
Higher stigma was associated with 
lower medication adherence (r = 
−0.18, p=.05), lower levels of 
information (r = −0.28, p b .05), 
motivation (r = −0.55, p b .05), 
and behavioral skills (r = −0.41, p 
b .05). Adherence information, 
motivation, and behavioral skills 
explained nearly all of the 










N = 50 Hispanic 
epilepsy clinic 
patients of Mexican 
descent in the US 
(age = 18+ years, 
mean age = 38.6 
years) 
Edited version of the Parent 
Stigma Scale, the Epilepsy 
Self-Efficacy Scale, the 
Interpersonal Support 
Evaluation List (ISEL), the 
Family Emotional Involvement 
and Criticism Scale (FEICS), 
the Patient Health 
Questionnaire 9 (PHQ-9), the 
Acculturation Rating Scale for 







Stigma and depression 
(r=.39). 
Stigma and social support 
(r=-.65). 
Stigma was positively correlated 
with depression (r=0.39, p<0.01) 
and negatively associated with 
social support (r=-0.65, <0.001). 
Stigma was not significantly 
correlated with perceived 
criticism, emotional involvement, 
self-efficacy, or national 
orientation. 
5 










N = 314 adult men 
and women with 
epilepsy recruited 
from “Project 
EASE” in the US 
(age = 19 to 75 
years, mean age = 
43 years) 
The Parent Stigma Scale 
modified for use to measure 
stigma in adults, the Epilepsy 
Self-Efficacy Scale, the 
Epilepsy Self-Management 
Scale, the Self-Reported 
Medication-Taking Scale, the 
Patient Satisfaction 
Questionnaire—III, 








Stigma and self-efficacy to 
manage epilepsy (r=−.431). 
Stigma and outcome 
expectancies related to 
treatment (r=−.213) and 
seizures (r=.652). 
Stigma and medication 
management (r=−.200). 
Stigma and medication 
adherence (r=.202). 
Stigma and patient 
satisfaction (r=−.190 to 
−.350).  
Stigma and expectancies 
related to information 
management (r=.159). 
Higher stigma was associated with 
lower self-efficacy to manage 
epilepsy (r=−0.431); more 
negative outcome expectancies 
related to treatment (r=−0.213) 
and seizures (r=0.652); and lower 
levels of medication management 
(r=−0.200), medication adherence 
(r=0.202), and patient satisfaction 
(r=−0.190 to −0.350). However, 
stigma was associated with more 
positive outcome expectancies 
related to information management 
(r=0.159). In regression analysis, 
income, age at first seizure, 
seizures during the past year, 
lower self-efficacy, negative 
outcome expectancies for seizures, 
and less patient satisfaction 
explained 54% of the variance in 
perceived stigma. 
7 




Letz, Henry, and 
Schomer (2004) 
 
*Used the same 
sample as DiIorio 




N = 317 PWE 
recruited from 
“Project EASE” in 
the US (age = 19-75 
years, mean age = 
43.3 years) 
Modified version of The Parent 
Stigma Scale (expanded to 10 
items), Epilepsy Self-Efficacy 
Scale, Epilepsy Self-Efficacy 
Scale, Epilepsy Regimen-
Specific Support Scale, 
Personal Resource 
Questionnaire 85 Part 2 
(PRQ85-2), Center for 
Epidemiologic Studies 
Depression Scale (CES-D), 
Patient Satisfaction 
Questionnaire-III, 
Multidimensional Desire for 
Control Scale 
Path analysis Not reported Stigma was directly related to self-
efficacy and depressive symptoms. 
Stigma was indirectly related to 
medication self-management 
through its association with self-
efficacy. These results suggest that 
those who feel highly stigmatized 
because of their epilepsy are less 




Letz, Henry,  and 
Schomer, (2006) 
*Used the same 







N = 272 PWE 
recruited from 
“Project EASE” in 
the US (age = 19-74 
years, mean age = 
43.7 years) 
The Epilepsy Stigma Scale, 
The Epilepsy Self-Efficacy 
Scale, The Epilepsy Self-
Management Scale, The 
Personal Resource 
Questionnaire 85 Part 2 
(PRQ85-2), The Epilepsy 
Regimen Specific Support 
Scale, The Patient Satisfaction 
Questionnaire-III (PSQ), The 
Center for Epidemiologic 




Not reported Stigma was a potentially 
significant predictor of self-
efficacy (F=3.643, 
p<0.057)but was less important 
than self-management, depressive 
symptoms and seizure severity. 
The inverse relationship found 
between perceived stigma and 
self-efficacy suggests that those 
who harbor negative thoughts 
about epilepsy also feel less 
confident in their ability to manage 
epilepsy. 
7 






*Used the same 
sample as Dilorio 




N = 319 PWE 
recruited from 
“Project EASE” in 
the US (age = 19-75 
years, mean age = 
43.3 years)  
Epilepsy Stigma Scale, Center 
for Epidemiologic Studies 
Depression Scale (CES-D), 
Epilepsy Self-Management 
Scale (ESMS), Epilepsy Self-
Efficacy Scale (ESES), Self-
Reported Medication-Taking 
Scale, Personal Resource 









Stigma and depression at 
baseline, 3 and 6-month 
follow-up (r=.425, .343 and 
.371, respectively). 
Stigma was correlated with 
depression at baseline, 3- and 6-
month follow-up (r=.425, .343 and 
.371, respectively, p<.001). The 
third main predictor of depressive 




and Yeager (2010) 
 
*Used a subset of 
the same sample 




N = 147 adults with 
epilepsy recruited 
from “Project 
EASE” in the US 
(age = 19-75 years, 
mean age = 45 
years) 
10-item scale adapted from the 
Parent Stigma Scale, 31-item 
Quality of Life in Epilepsy 
(QOLIE-31) scale, adapted 
from the more comprehensive 
89-item scale, Center for 
Epidemiologic Studies 
Depression Scale (CES-D), 
Personal Resource 





Stigma and QOL (r=−.513). Statistically significant negative 
correlations were found between 
depressive symptoms, stigma and 
sometimes regimen-specific 
support and QOL. In regression 
analyses, stigma was found to 
predict QOL at a later time. 
7 
Elliott, Jacobson, 




N = 94 epilepsy 
patients in the US 
(age = 19-78 years, 
mean age = 45 
years) 
The Liverpool Stigma Scale 
(LSS), the Osteoporosis 
Knowledge Test (OKT), the 
Osteoporosis Health Belief 
Scale (OHBS), the 
Osteoporosis Self-Efficacy 
Scale (OSES), the Quality of 
Life in Epilepsy (QOLIE-31) 
scale, and the Epilepsy Self-





Not reported The Liverpool Stigma Scale did 
not predict any of the dependent 
variables (self-efficacy for 
calcium, exercise, and epilepsy 
self-management). 
6.5 












N = 101 PWE in 
Canada (age = 18-
65 years, mean age 
= 37.51 years) 
Jacoby 3-item measure of 
stigma, the Social Phobia 
Inventory (SPIN), the Hospital 
Anxiety and Depression Scale 
(HADS), the Epilepsy 
Knowledge Questionnaire 
(EKQ), the Liverpool Seizure 
Severity Scale (LSSS), the 
Impact of Epilepsy scale, the 
Disclosure Management Scale, 
Brief Fear of Negative 
Evaluation (BFNE) scale, 









Stigma and social anxiety 
(r=.48). 
Social anxiety positively 
correlated with felt stigma (r=.48, 
p<.001). This relationship 
remained significant after 
controlling for depression 
(p<.001). Social anxiety 
significantly predicted the variance 
in stigma above and beyond age, 
anxiety, impact of epilepsy, 
seizure frequency, and depression 








Epilepsy group N = 
64 older adults with 
epilepsy in Australia 
(age = 60+ years, 
mean age = 67.59 
years). Control 
group N = 60 adults 
recruited from the 
general community 
in Australia (age 
60+ years, mean age 
= 66.50 years) 
3-Item Stigma scale, Mini 
mental state exam (MMSE), 
Washington Psychosocial 
Seizure Inventory (WPSI), 







Not reported Stigma contributed significantly to 
prediction of HRQOL (sr2 = .21). 
A greater perception of stigma was 
strongly related to poor quality of 
life and reduced psychosocial 
function. Less stigma and lower 
frequency of seizures uniquely 
contributed to the overall 
prediction of better HRQOL. 
Overall, the predictors of stigma 
and seizure frequency together 
accounted for 54% of the 
variability in HRQOL. 
5.5 
Study Design Participants Measures Analysis Effect size (Pearson’s r) Findings/Authors’ Conclusions Quality 
Appraisal 
Rating 





N = 52 people with a 
diagnosis of 
epilepsy attending 
an outpatient clinic 
in Northern Ireland  
Jacoby 3-item measure of 
stigma; Perceived Severity of 
Epilepsy Scale; Perceived 
Acceptance Scale; Questions 
relating to epilepsy and seizure 
type and frequency 
Correlation 
(r) 
Stigma and seizure severity 
(r=.37).  
Stigma and perceived 
acceptance (r=-.35). 
Seizure severity was significantly 
correlated with perception of 
stigma (r=.37, p<.01). A 
significant negative correlation 
were found between perceived 








N = 503 PWE in the 
UK and Republic of 
Ireland (age = 18-79 
years, median age = 
37 years) 
Jacoby 3-item measure of 
stigma, the Faux Pas Task-
Short Version (FPT), the 






Stigma and theory of mind 
performance (r=-.02 on the  
RMET and r=-.05 on the 
FPT). 
Feelings of stigma held a 
negligible, negative, and 
nonsignificant association with 
ToM performance (r=-.02 and -
.05). The ToM model for 









N = 300 PWE in 
Australia 




participants on the 
Australian Epilepsy 
Research Register 
(AERR) (age = 18+ 
years)  
Stigma scale emerging from 
factor analysis of items 
principally derived from the 
Child Asthma scale (including 
social scale and personal scale 
subscales), the Hospital 







Not reported Significant correlations were 
found between anxiety and 
depression and stigma. Social 
aspects of stigma significantly 
predicted depression and anxiety 
(B=.34 and .32, respectively, 
p<.01) when gender, age and 
epilepsy-related variables had been 
controlled for. Social aspects of 
stigma had the strongest effect on 
anxiety, followed by the 
effectiveness of current control on 
seizures. Those who take more 
epilepsy drugs experienced greater 
stigma as a result and, therefore, 
had higher rates of depression and 
anxiety. 
4.5 












n = 181 PWE and n 
= 178 biologic 
relatives without 
epilepsy in the US 
(N = 359; mean age 
= 52 years) 
Epilepsy Stigma Scale (ESS), 
Family Epilepsy Stigma Scale 
(FESS), three questions related 












Not reported Felt stigma was higher among 
individuals who were aged >/=60 
years, were unemployed, reported 
epilepsy-related discrimination, or 
had seizures within the last year or 
>100 seizures in their lifetime. 
Adjusting for other variables, ESS 
scores in people with epilepsy 
were significantly higher among 
those who perceived genetics 
played a "medium" or "big" role in 
causing epilepsy in the family than 









N = 244 adults with 
epilepsy in the US 
(age = 18+ years) 
The Stigma Scale (8 questions 
modified from the scale 
developed by Dilorio), the 







Not reported Reported levels of stigma were 
associated with interactions of 
seizure worry and employment 
status (disabled or unemployed 
with higher seizure worry=higher 
stigma), self-efficacy and social 
support (higher scores=lower 
stigma), and quality of care and 
age at seizure onset (higher quality 
of care and over 40=lower stigma).  
6 








survey   
N = 210 PWE 
attending outpatient 
clinics in The 
Netherlands (age = 
18-65 years, mean 
age = 38 years) 
Perception of stigma of 
epilepsy (PSE), Perception of 
epilepsy seizures (PES), Health 
perceptions (HP), Life-
fulfillment questionnaire 
(LFQ), Loneliness scale (LS), 
General adjustment to epilepsy 
(GATE), Self-esteem (RSE), 
Mastery (MAS), Mental health 
(MH), Psychological distress 








Stigma and QOL (r=0.17).  Perception of stigma in epilepsy 
was negatively correlated with 
QOL (r=0.17, p<.01). In 
decreasing order of importance, 
psychological distress, loneliness, 
adjustment and coping, and stigma 
perception (B=.17, p=.4) 
contributed most significantly to 
QoL.  
7 






N = 1566 adults with 
epilepsy in the UK 
(mean age = 40 
years) 
The Revised Stigma Scale, the 
Newly Diagnosed Epilepsy 









Stigma and anxiety (r=.41). 
Stigma and depression 
(r=.41). 
Stigma and mastery (r=-
.41). 
Stigma and cognitive 
effects of anti-epileptic 
drugs (r=.43). 
Stigma and adverse events 
(r=.45). 
Felt stigma was associated with 
younger age, a previous or current 
neurological disorder, being 
unmarried, experiencing more 
seizures, having no formal 
educational qualifications on 
leaving school, and being 
unemployed. Gender, seizure type, 
presence of a neurological deficit, 
and social class were not 
associated with degree of felt 
stigma. A multivariate linear 
regression demonstrated that 
scores on the AEP, mastery scale, 
and ABNAS, poor overall global 
QOL, age < 50 years, more than 
four seizures at baseline, and 
feeling more socially restricted 
were significant predictors of 
stigma. 
6.5 






n = 94 patients with 
refectory epilepsy 
(RE) and n = 70 
patients with 
pharmacosensitive 
epilepsy (PSE) in 
Bulgaria (N = 164; 
age = 18-65 years, 
mean age = 41.72 
years)  
Jacoby 3-item measure of 
stigma, the Beck Depression 
Inventory (BDI-II), the 
Hamilton Anxiety Scale 
(HAS), the Liverpool Seizure 
Severity Scale (LSSS), and 
Correlation 
(r) 
Stigma and depression 
(r=.40).  
Stigma and mental status 
impairment (r=.19). 
No correlation was found between 
stigma and age and gender, 
education, marital status, 
employment, seizure frequency 
and severity, prescribed treatment, 
or anxiety (Р > 0.05). A moderate 
correlation was found between 
depression and stigmatization 
frequency and severity (r=.40, 
Р< .01). A mild correlation was 
found between mental status 
impairment and stigmatization. 
Mental status impairment was 
associated with a more frequent 
and more severe stigmatization 
(r=.19 , P<.05). 
5 
Viteva (2013) 
*Used the same 





N = 140 PWE (70 
patients with 
refectory epilepsy 
and 70 patients with 
pharmacosensitive 
epilepsy) in Bulgaria 
(age = 18-65 years, 
mean age =  41.7 
years) 
Jacoby 3-item measure of 
stigma, the Health Related 




Stigma and QOL (r=−.6). Stigma had a negative impact on 
QOL (T-score 47.8), including all 
sub-scales of QOLIE-89, with the 
exception of “change in health” 
and “sexual relations”. There was 
a negative correlation of all 
QOLIE-89 sub-scales with 
perceived stigma severity. 
5 












Bulgaria (age = 18-
65 years, mean age 
= 44.88 years) 
The stigma scale, the Glasgow 
Depression Scale for people 
with a Learning Disability 
(GDS-LD),4 the Glasgow 
Anxiety Scale for people with 
Intellectual Disability (GAS-
ID), The Liverpool Seizure 
Severity Scale (LSSS), The 
Glasgow Epilepsy Outcome 
Scale (GEOS-35), the carer 







Stigma and health-related 
QOL (r=.43). 
GEOS-35 total scores were 
associated with seizure frequency 
and severity, stigma, depression, 
and anxiety. On multivariate 
regression analysis predictors of 
the GEOS-35 total score were 
anxiety, seizure severity, and 
stigma Р < 0.001 (F = 14.66). 
Regarding GEOS-35 sub-scales, 
on multivariate regression analysis 
seizure severity and stigma were 
predictors of “concerns about 
social impact” Р < 0.001 






*Used the same 









Bulgaria (age = 18-
65 years, mean age 
= 44.88 years) 
The stigma scale for people 
with intellectual impairment 
(10-item), Evaluation rapide 
des fonctions cognitives 
(ERFC), interview about 
enacted stigma comprising four 
statements about a real 





Stigma and discrimination 
(r=.71). 
Stigma and experienced 
insults and threats and/or 
attacks (r=.43) 
Participants who gave a greater 
number of positive answers about 
experienced discrimination or 
insults and/or threats and attacks 
reported a more pronounced 
perceived stigma (F=19.30, 
P<0.001 and F=12.91, P<0.001, 
respectively). Perceived stigma 
and the experience of insults 
and/or threats and attacks proved 
to be predictors of discrimination 
on multivariate regression analysis 
(F=40.54, P<0.001).  
5 






N = 153 patients 
with epilepsy in 
Bulgaria (age = 18-
65 years, mean age 
= 39.34 years) 
Jacoby 3-item measure of 
stigma, the Liverpool Adverse 





Stigma and the presence of 
neurological and 
psychiatric adverse events 
(r=.60). 
 
Stigma and the presence of 
non-neurological adverse 
events (r=.20). 
A significant correlation between 
perceived stigma and the presence 
of neurological and psychiatric 
AEs (p < 0.001, r = +0.60) and a 
mild correlation between 
perceived stigma and the presence 
of non-neurological AEs (p < 0.01, 
r = +0.20) was identified. In a 
multivariate regression analysis 
the only predictors of perceived 
stigma were AED polytherapy and 











N = 70 patients with 
epilepsy in Turkey 
(age = 18-70 years, 
mean age = 31.7 
years) 
Jacoby 3-item measure of 
stigma, The Epilepsy Attitude 
Scale, the Epilepsy Knowledge 
Scale, Rotter's Locus of 
Control Scale, the Hospital 
Anxiety and Depression Scale 










Stigma and attitude towards 
epilepsy (r=−.267). 
Stigma and anxiety 
(r=.283). 
Stigma and depression, 
r=.282). 
Stigma and QOL epilepsy 
effects (r=−.255). 
Stigma and QOL role 
functioning (r=−.336). 
Significant correlations were 
obtained between stigma and 
attitude towards epilepsy (r=−.267, 
p=.026), anxiety and depression 
(r=.283, p=.018, r=.282, p=.018), 
QOL epilepsy effects (r=−.255, 
p=.033), and QOL role functioning 
(r=−.336, p=.004). 
4 
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N = 194 patients 
with epilepsy in 
Turkey (age = 18-80 
years, mean age = 
31.4 years) 
Jacoby 3-item measure of 
stigma, the Multidimensional 
Scale of Perceived Social 
Support (MSPSS), the Social 
Support Scale, the General 
Self-Efficacy Scale, the 
Epilepsy Knowledge 
Questionnaire, and the 








Stigma and social support 
(r=−.3) 
Stigma and knowledge of 
epilepsy (r=−.18). 
Stigma and attitudes 
towards epilepsy (r=-.152). 
Stigma and and self-
efficacy (r=-.185). 
Education (χ2=8.23, p=.016), 
income (χ2=9.735, p=.008), age at 
onset (r=−0.183, p=.01), seizure 
frequency in previous year 
(χ2=9.26, p=.01), social support 
(r=−.3, p=.001), and knowledge 
and attitudes towards epilepsy 
(r=−.18, p=.012, r=-.152, p=.034) 
were significant factors 
determining stigma. It was also 
determined that stigma was 
associated with seeking non-
medical help (Z=3.60, p=.001), 
disclosure of the diagnosis 
(Z=2.59, p=.01), and self-efficacy 




Figure 1.Flow chart of search and inclusion/exclusion process 
 
 
